Sublingual Immunotherapy in Patients With Atopic Dermatitis

PHASE2CompletedINTERVENTIONAL
Enrollment

239

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Atopic Dermatitis
Interventions
BIOLOGICAL

Dermatophagoides Farinae Drops Group 1

Dermatophagoides Farinae Drops Group 1 is the group with maintenance dose of 2 drops of grade 5 Dermatophagoides Farinae and 1 drop of placebo.

BIOLOGICAL

Dermatophagoides Farinae Drops Group 2

Dermatophagoides Farinae Drops Group 2 is the group with maintenance dose of one drop of grade 5 Dermatophagoides Farinae and 2 drop of placebo.

BIOLOGICAL

Dermatophagoides Farinae Drops Group 3

Dermatophagoides Farinae Drops Group 3 is the group with maintenance dose of 3 drops of grade 4 Dermatophagoides Farinae.

BIOLOGICAL

Placebo

Placebo Group is the group with maintenance dose of 3 drops of placebo.

Trial Locations (1)

310009

Second Affiliated Hospital,School of Medicine,Zhejiang University., Hangzhou

All Listed Sponsors
collaborator

Wolwo Bio-pharmaceutical Co. LTD.

UNKNOWN

collaborator

Huashan Hospital

OTHER

collaborator

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

OTHER

collaborator

Peking University Third Hospital

OTHER

collaborator

Tongji Hospital

OTHER

collaborator

First Affiliated Hospital of Suzhou Medical College

OTHER

lead

Zhejiang University

OTHER

NCT01471119 - Sublingual Immunotherapy in Patients With Atopic Dermatitis | Biotech Hunter | Biotech Hunter